These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 9358567)
1. A new approach for direct in vivo dissolution studies of poorly soluble drugs. Bønløkke L; Christensen FN; Knutson L; Kristensen HG; Lennernäs H Pharm Res; 1997 Oct; 14(10):1490-2. PubMed ID: 9358567 [No Abstract] [Full Text] [Related]
2. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test. Takano R; Sugano K; Higashida A; Hayashi Y; Machida M; Aso Y; Yamashita S Pharm Res; 2006 Jun; 23(6):1144-56. PubMed ID: 16715363 [TBL] [Abstract][Full Text] [Related]
3. A comparison between direct determination of in vivo dissolution and the deconvolution technique in humans. Bønløkke L; Hovgaard L; Kristensen HG; Knutson L; Lindahl A; Lennernäs H Eur J Pharm Sci; 1999 Apr; 8(1):19-27. PubMed ID: 10072475 [TBL] [Abstract][Full Text] [Related]
4. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations. Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828 [TBL] [Abstract][Full Text] [Related]
5. Accounting for the solubility-permeability interplay in oral formulation development for poor water solubility drugs: the effect of PEG-400 on carbamazepine absorption. Beig A; Miller JM; Dahan A Eur J Pharm Biopharm; 2012 Jun; 81(2):386-91. PubMed ID: 22387337 [TBL] [Abstract][Full Text] [Related]
6. Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process. Kataoka M; Fukahori M; Ikemura A; Kubota A; Higashino H; Sakuma S; Yamashita S Eur J Pharm Biopharm; 2016 Apr; 101():103-11. PubMed ID: 26873006 [TBL] [Abstract][Full Text] [Related]
7. An improved prediction of the human in vivo intestinal permeability and BCS class of drugs using the in vitro permeability ratio obtained for rat intestine using an Ussing chamber system. Li H; Jin HE; Shim WS; Shim CK Drug Dev Ind Pharm; 2013 Oct; 39(10):1515-22. PubMed ID: 22934579 [TBL] [Abstract][Full Text] [Related]
8. Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies. Kleberg K; Jacobsen J; Müllertz A J Pharm Pharmacol; 2010 Nov; 62(11):1656-68. PubMed ID: 21039549 [TBL] [Abstract][Full Text] [Related]
9. A reaction limited in vivo dissolution model for the study of drug absorption: Towards a new paradigm for the biopharmaceutic classification of drugs. Macheras P; Iliadis A; Melagraki G Eur J Pharm Sci; 2018 May; 117():98-106. PubMed ID: 29425862 [TBL] [Abstract][Full Text] [Related]
10. Biopharmaceutical classification of drugs using intrinsic dissolution rate (IDR) and rat intestinal permeability. Zakeri-Milani P; Barzegar-Jalali M; Azimi M; Valizadeh H Eur J Pharm Biopharm; 2009 Sep; 73(1):102-6. PubMed ID: 19442726 [TBL] [Abstract][Full Text] [Related]
11. Striking the Optimal Solubility-Permeability Balance in Oral Formulation Development for Lipophilic Drugs: Maximizing Carbamazepine Blood Levels. Beig A; Miller JM; Lindley D; Dahan A Mol Pharm; 2017 Jan; 14(1):319-327. PubMed ID: 27981848 [TBL] [Abstract][Full Text] [Related]
12. Considerations for the development of in vitro dissolution tests to reduce or replace preclinical oral absorption studies. Grignard E; Taylor R; McAllister M; Box K; Fotaki N Eur J Pharm Sci; 2017 Mar; 99():193-201. PubMed ID: 27940084 [TBL] [Abstract][Full Text] [Related]
13. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim. Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464 [TBL] [Abstract][Full Text] [Related]
14. Intestinal solubility and absorption of poorly water soluble compounds: predictions, challenges and solutions. Fagerberg JH; Bergström CA Ther Deliv; 2015; 6(8):935-59. PubMed ID: 26316058 [TBL] [Abstract][Full Text] [Related]
15. Physical chemistry of supersaturated solutions and implications for oral absorption. Taylor LS; Zhang GGZ Adv Drug Deliv Rev; 2016 Jun; 101():122-142. PubMed ID: 27013254 [TBL] [Abstract][Full Text] [Related]
16. Prediction of human pharmacokinetics--gastrointestinal absorption. Fagerholm U J Pharm Pharmacol; 2007 Jul; 59(7):905-16. PubMed ID: 17637184 [TBL] [Abstract][Full Text] [Related]
17. Proceedings: The viability of the vascularly perfused jejunal loop of the rat and its significance for the drug absorption. Ochsenfahrt H Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R71. PubMed ID: 4276625 [No Abstract] [Full Text] [Related]
18. Regional intestinal drug permeation: biopharmaceutics and drug development. Lennernäs H Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845 [TBL] [Abstract][Full Text] [Related]
19. Jejunal permeability: a comparison between the ussing chamber technique and the single-pass perfusion in humans. Lennernäs H; Nylander S; Ungell AL Pharm Res; 1997 May; 14(5):667-71. PubMed ID: 9165541 [No Abstract] [Full Text] [Related]
20. Comparison of biorelevant simulated media mimicking the intestinal environment to assess the solubility profiles of poorly soluble drugs. Prasad D; Gu CH; Kuldipkumar A Pharm Dev Technol; 2016; 21(4):511-7. PubMed ID: 25703029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]